FDA Inspection
Aurobindo Pharma LtdAurobindo Pharma Ltd – FDA Inspection, Sep 24, 2010
Record Details
This FDA Inspection record concerns Aurobindo Pharma Ltd, with an inspection on September 24, 2010, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Aurobindo Pharma Ltd
- Inspection Date
- September 24, 2010
- Product Type
- Drugs
View Company Profile
ID · 54d9f7dd-5d8b-4963-9b38-47f689a0441e
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 684552
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Aurobindo Pharma Ltd
11| Date | Classification | Office | Project area |
|---|---|---|---|
| July 21, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 5, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 24, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 10, 2018 | VAI | Center for Drug Evaluation and Research | Postmarket Surv. and Epidemiology |
| April 18, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Aurobindo Pharma Ltd
- FDA Inspection 1210950 - 2023-07-21
- FDA Inspection 1155879 - 2019-07-05
- FDA Inspection 1090627 - 2019-05-24
- FDA Inspection 1061698 - 2018-08-10
- FDA Inspection 1010385 - 2017-04-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.